(PDF) Aberrant Expression of Centractin and Capping

Aberrant Expression of Centractin and Capping Proteins, Integral Constituents of the Dynactin Complex, in Fetal Down Syndrome Brain

Biochemical and Biophysical Research Communications - United States

doi 10.1006/bbrc.2002.6389

Full Text

Abstract

Available in full text

Categories

Molecular Biology

Date

February 1, 2002

Authors

Talin Gulesserian

Michael Fountoulakis

Publisher

Elsevier BV

Related search

The P150Glued Component of the Dynactin Complex Binds to Both Microtubules and the Actin-Related Protein Centractin (Arp-1).

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Outer Brain Oscillations in Down Syndrome

Frontiers in Systems Neuroscience

Molecular Neuroscience

Developmental Neuroscience

Cognitive Neuroscience

English

307: Perinatal Outcomes of Pregnancies With Fetal Down Syndrome

American Journal of Obstetrics and Gynecology

English

Stochastic Simulation Study of the Role of Capping and Anti-Capping Proteins in Regulating Actin Network Growth

Biophysical Journal

English

Centractin (ARP1) Associates With Spectrin Revealing a Potential Mechanism to Link Dynactin to Intracellular Organelles

Journal of Cell Biology

English

Fetal Hypoxia Results in Programming of Aberrant Angiotensin II Receptor Expression Patterns and Kidney Development

International Journal of Medical Sciences

English

Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology

Antioxidants and Redox Signaling

Molecular Biology

Clinical Biochemistry

English

An Evolutionarily Distinct Family of Polysaccharide Lyases Removes Rhamnose Capping of Complex Arabinogalactan Proteins

Journal of Biological Chemistry

Molecular Biology

English

Evolution of the Eukaryotic Dynactin Complex, the Activator of Cytoplasmic Dynein

BMC Evolutionary Biology

English